Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study

Prostate Cancer and Prostatic Diseases

Volumn 10, Issue 3, 2007, Pages 283-287

  Manoharan, M ^a   Ayyathurai, R ^a   Nieder, A M ^a   Soloway, M S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; DIGITAL RECTAL EXAMINATION; DISEASE DURATION; EJACULATION; HEMOSPERMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; OBSERVATIONAL STUDY; PATIENT COUNSELING; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SEMEN ANALYSIS; SEXUAL BEHAVIOR; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; HEMOSPERMIA; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 34548449465     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500955     Document Type: Article

References (29)

1. Schroder FH, Bangma CH. The European Randomized Study of Screening for Prostate Cancer (ERSPC). Br J Urol 1997; 79 (Suppl. 1): 68-71.
2. Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European prostate cancer detection study. J Urol 2001; 166: 856-860.
3. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989; 142 66-70.
4. Stricker HJ, Ruddock LJ, Wan J, Belville WD. Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol 1993; 71: 43-46.
5. Presti Jr JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial. J Urol 2000; 163: 163-166; discussion 166-167.
6. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores. J Urol 2000; 163: 168-171.
7. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature. J Urol 1998; 160: 2115-2120.
8. Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: Complications and acceptance by patients. Br J Urol 1993; 71: 457-459.
9. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies - true morbidity and patient acceptance. Br J Urol 1993; 71: 460-463.
10. Gustafsson O, Norming U, Nyman CR, Ohstrom M. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 1990; 24: 249-251.
11. Thompson PM, Pryor JP, Williams JP, Eyers DE, Dulake C, Scully MF et al. The problem of infection after prostatic biopsy: The case for the transperineal approach. Br J Urol 1982; 54: 736-740.
12. Thompson PM, Talbot RW, Packham DA, Dulake C. Transrectal biopsy of the prostate and bacteraemia. Br J Surg 1980; 67: 127-128.
13. Djavan B, Zlotta A, Kratzik C, Remzi M, Seitz C, Schulman CC et al. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml. Urology 1999; 54: 517-522.
14. Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998; 160: 411-418; discussion 418-419.
15. Brawer MK, Chetner MP. Ultrasonography of the Prostate and Biopsy. W.B. Saunders Co: Philadelphia, 1998, pp 2506-2518.
16. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC et al. Optimal predictors of prostate cancer on repeat Prostate Biopsy: a prospective study of 1051 men. J Urol 2000; 163: 1144-1148; discussion 1148-1149.
17. Munkel witz R, Krasnokutsky S, Lie J, Shah SM, Bayshtok J, Khan SA. Current perspectives on hematospermia: A review. J Androl 1997; 18: 6-14.
18. Kumar P, Kapoor S, Nargund V. Haematospermia - a systematic review. Ann R Coll Surg Engl 2006; 88: 339-342.
19. Han M, Brannigan RE, Antenor JA, Roehl KA, Catalona WJ. Association of hemospermia with prostate cancer. J Urol 2004; 172: 2189-2192.
20. Bihrle R, Foster RS, Sanghvi NT, Donohue JP, Hood PJ. High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. J Urol 1994; 151: 1271-1275.
21. Jones DJ. Haemospermia: A prospective study. Br J Urol 1991; 67 88-90.
22. Torp-Pedersen S, Lee F, Littrup PJ, Siders DB, Kumasaka GH, Solomon MH et al. Transrectal biopsy of the prostate guided with transrectal US: Longitudinal and multiplanar scanning. Radiology 1989; 170 23-27.
23. de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003; 61: 1181-1186.
24. Mkinen T, Auvinen A, Hakama M, Stenman UH, Tammela TL. Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: A prospective, controlled study. Urology 2002; 60: 846-850.
25. Rietbergen JB, Kruger AE, Kranse R, Schroder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population-based screening program. Urology 1997; 49: 875-880.
26. Clements R, Aideyan OU, Griffiths GJ, Peeling WB. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 1993; 47: 125-126.
27. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: A study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int 2004; 94 1014-1020.
28. Wammack R, Djavan B, Remzi M, Susani M, Marberger M. Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression. Urology 2001; 58: 1004-1007.
29. Maan Z, Cutting CW, Patel U, Kerry S, Pietrzak P, Perry MJ et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 2003; 91: 798-800.